The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.0M data for 1.3M Compounds and 9.6K Targets. Of those, 1.5M data for 695K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Advanced Search

11 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Illuminating the binding interactions of galactonoamidines during the inhibition ofß-galactosidase (E. coli).EBI
University of Arkansas
Inhibition studies of some serine and thiol proteinases by new leupeptin analogues.EBI
University of Arkansas
Kinase inhibitor macrocycles: a perspective on limiting conformational flexibility when targeting the kinome with small molecules.EBI
University of Arkansas
FLT3 inhibitors for acute myeloid leukemia: successes, defeats, and emerging paradigms.EBI
University of Arkansas
Structure-activity relationship of highly potent galactonoamidine inhibitors toward β-galactosidase (Aspergillus oryzae).EBI
University of Arkansas
New leupeptin analogues: synthesis and inhibition data.EBI
University of Arkansas
New pepstatin analogues: synthesis and pepsin inhibition.EBI
University of Arkansas
Picomolar inhibition ofβ-galactosidase (bovine liver) attributed to loop closure.EBI
University of Arkansas
4-aminopyrimidine derivatives and their as as adenosine A2a receptor antagonistsBDB
Palobiofarma
Scaffold hopping, synthesis and structure-activity relationships of 5,6-diaryl-pyrazine-2-amide derivatives: a novel series of CB1 receptor antagonists.BDB
Astrazeneca
Structure-guided design of potent and selective pyrimidylpyrrole inhibitors of extracellular signal-regulated kinase (ERK) using conformational control.BDB
Vertex Pharmaceuticals